Ligan, Gilmhar B.

HRN: 24-18-63  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/11/2023
12/18/2023
IV
300mg
1 Hour PTOR Then Q8hr
Panfacial Fracture
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: